Belgravia Hartford Cap Inc. (BLGVF)

[PotterBanker]

Belgravia Completes Transition of ICP Organics to Dermatology Product Development, Renames ICP Organics to Belgravia Dermatology Inc., and Appoints Sidney Himmel Director of Belgravia Dermatology

TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) today announced that it has completed the strategic transition of ICP Organics, the fully owned subsidiary of Belgravia, to a cannabinoid-based dermatology ethical drug research and product development company. Further, the name of ICP Organics, the dermatology division of Belgravia, is being changed to Belgravia Dermatology Inc. (“Belgravia Dermatology”). The Company has also announced today that Sidney Himmel has been appointed as director of Belgravia Dermatology.

https://globenewswire.com/news-release/2018/05/11/1500957/0/en/Belgravia-Completes-Transition-of-ICP-Organics-to-Dermatology-Product-Development-Renames-ICP-Organics-to-Belgravia-Dermatology-Inc-and-Appoints-Sidney-Himmel-Director-of-Belgravia.html